(NASDAQ: COCH) Envoy Medical's forecast annual revenue growth rate of -5.06% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.95%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.93%.
Envoy Medical's revenue in 2024 is $316,000.On average, 1 Wall Street analysts forecast COCH's revenue for 2024 to be $5,879,995, with the lowest COCH revenue forecast at $5,879,995, and the highest COCH revenue forecast at $5,879,995.
In 2025, COCH is forecast to generate $5,879,995 in revenue, with the lowest revenue forecast at $5,879,995 and the highest revenue forecast at $5,879,995.